Senior insider sale
Chief Scientific Officer at ADAPTIVE BIOTECHNOLOGIES CORP — senior position signals high conviction
$8.18M
547.29K shares
ROBINS HARLAN S plans to sell 547.29K shares of ADAPTIVE BIOTECHNOLOGIES CORP valued at approximately $8.18M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Units
N/A
Performance Stock Units
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/10/2026 | Restricted Stock Units N/A | 140.67K | — |
3/10/2026 | Performance Stock Units N/A | 329.60K | — |
| Total | 470.27K | ||
Completed
Units to sell
14.23K
Market value
$235.1K
Units to sell
10K
Market value
$157.2K
Units to sell
7.61K
Market value
$144.3K
Units to sell
515.00
Market value
$10.0K
Units to sell
2.40K
Market value
$44.1K
Units to sell
32.27K
Market value
$600.7K
Units to sell
10K
Market value
$164.4K
Planned — Approximate Date
Units to sell
470.27K
Market value
$6.83M
Units
547.29K
Value
$8.18M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/3/2026 | 14.23K | $235.1K | — | Completed |
3/2/2026 | 10K | $157.2K | — | Completed |
2/3/2026 | 7.61K | $144.3K | — | Completed |
2/3/2026 | 515.00 | $10.0K | — | Completed |
2/2/2026 | 2.40K | $44.1K | — | Completed |
2/2/2026 | 32.27K | $600.7K | — | Completed |
1/6/2026 | 10K | $164.4K | — | Completed |
| Planned — Approximate Date | ||||
3/11/2026 | 470.27K | $6.83M | NASDAQ | Planned |
| Total | 547.29K | $8.18M | ||